Reviva Pharmaceuticals Holdings (RVPH) Cash & Equivalents (2018 - 2026)
Reviva Pharmaceuticals Holdings' Cash & Equivalents was $19.89 million in Q2 2026, up 91.9% from $10.36 million a year earlier but down 10.4% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Reviva Pharmaceuticals Holdings came in at $14.44 million, up 7.1% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 10.5% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $13.48 million in FY2024 (-42.3%), $23.37 million in FY2023 (+26.2%) and $18.52 million in FY2022.
- Quarterly Cash & Equivalents has moved between $4.97 million (Q3 2023) and $33.49 million (Q3 2021) over five years.
- Compared with a year earlier, Cash & Equivalents has increased for five straight quarters, with growth averaging 67.1% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q1 2026 (growth of 319.5%); the worst was Q3 2023 (a decline of 78.6%).
- Per Business Quant data, RVPH's Cash & Equivalents in the three quarters before Q2 2026 was $22.19 million (Q1 2026), $14.44 million (Q4 2025) and $13.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Reviva Pharmaceuticals Holdings | 4.46 Mn | -82.75 Mn | - | 17.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 17.46 Mn |
| Jun 30, 2026 | 19.89 Mn |
| Mar 31, 2026 | 22.19 Mn |
| Dec 31, 2025 | 14.44 Mn |
| Sep 30, 2025 | 13.18 Mn |
| Jun 30, 2025 | 10.36 Mn |
| Mar 31, 2025 | 5.29 Mn |
| Dec 31, 2024 | 13.48 Mn |
| Sep 30, 2024 | 5.56 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Mar 31, 2024 | 11.97 Mn |
| Dec 31, 2023 | 23.37 Mn |
| Sep 30, 2023 | 4.97 Mn |
| Jun 30, 2023 | 11.15 Mn |
| Mar 31, 2023 | 11.26 Mn |
| Dec 31, 2022 | 18.52 Mn |
| Sep 30, 2022 | 23.19 Mn |
| Jun 30, 2022 | 19.42 Mn |
| Mar 31, 2022 | 23.42 Mn |
| Dec 31, 2021 | 29.69 Mn |
API Access
Reviva Pharmaceuticals Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();